Magni M - Search Results

1

A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation.

Restelli M, Magni M, Ruscica V, Pinciroli P, De Cecco L, Buscemi G, Delia D, Zannini L. Restelli M, et al. Among authors: magni m. Cell Death Dis. 2016 Nov 3;7(11):e2453. doi: 10.1038/cddis.2016.359. Cell Death Dis. 2016. PMID: 27809307 Free PMC article.

2

Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis.

Magni M, Ruscica V, Buscemi G, Kim JE, Nachimuthu BT, Fontanella E, Delia D, Zannini L. Magni M, et al. Nucleic Acids Res. 2014 Dec 1;42(21):13150-60. doi: 10.1093/nar/gku1065. Epub 2014 Oct 31. Nucleic Acids Res. 2014. PMID: 25361978 Free PMC article.

3

CCAR2/DBC1 is required for Chk2-dependent KAP1 phosphorylation and repair of DNA damage.

Magni M, Ruscica V, Restelli M, Fontanella E, Buscemi G, Zannini L. Magni M, et al. Oncotarget. 2015 Jul 10;6(19):17817-31. doi: 10.18632/oncotarget.4417. Oncotarget. 2015. PMID: 26158765 Free PMC article.

4

Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology.

Magni M, Buscemi G, Zannini L. Magni M, et al. Mutat Res Rev Mutat Res. 2018 Apr-Jun;776:1-9. doi: 10.1016/j.mrrev.2018.03.004. Epub 2018 Mar 19. Mutat Res Rev Mutat Res. 2018. PMID: 29807573 Review.

5

TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage.

Magni M, Buscemi G, Maita L, Peng L, Chan SY, Montecucco A, Delia D, Zannini L. Magni M, et al. Cell Death Differ. 2019 May;26(5):918-931. doi: 10.1038/s41418-018-0168-6. Epub 2018 Jul 26. Cell Death Differ. 2019. PMID: 30050056 Free PMC article.

6

Sex specific regulation of TSPY-Like 2 in the DNA damage response of cancer cells.

Cardano M, Magni M, Alfieri R, Chan SY, Sabbioneda S, Buscemi G, Zannini L. Cardano M, et al. Among authors: magni m. Cell Death Dis. 2023 Mar 15;14(3):197. doi: 10.1038/s41419-023-05722-2. Cell Death Dis. 2023. PMID: 36918555 Free PMC article.

7

Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.

Magni M, Biancon G, Rizzitano S, Cavanè A, Paolizzi C, Dugo M, Corradini P, Carniti C. Magni M, et al. Br J Cancer. 2019 Oct;121(7):567-577. doi: 10.1038/s41416-019-0557-8. Epub 2019 Sep 2. Br J Cancer. 2019. PMID: 31474759 Free PMC article.

8

Targeting the DNA Damage Response to Increase Anthracycline-Based Chemotherapy Cytotoxicity in T-Cell Lymphoma.

Magni M, Paolizzi C, Monfrini C, Vella C, Corradini P, Carniti C. Magni M, et al. Int J Mol Sci. 2022 Mar 30;23(7):3834. doi: 10.3390/ijms23073834. Int J Mol Sci. 2022. PMID: 35409194 Free PMC article.

9

Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma.

Carniti C, Caldarelli NM, Agnelli L, Torelli T, Ljevar S, Jonnalagadda S, Zanirato G, Fardella E, Stella F, Lorenzini D, Brich S, Arienti F, Dodero A, Chiappella A, Magni M, Corradini P. Carniti C, et al. Among authors: magni m. Blood Adv. 2024 Apr 23;8(8):1968-1980. doi: 10.1182/bloodadvances.2024012563. Blood Adv. 2024. PMID: 38359407 Free PMC article.

10

Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma.

Monfrini C, Stella F, Aragona V, Magni M, Ljevar S, Vella C, Fardella E, Chiappella A, Nanetti F, Pennisi M, Dodero A, Guidetti A, Corradini P, Carniti C. Monfrini C, et al. Among authors: magni m. Clin Cancer Res. 2022 Aug 2;28(15):3378-3386. doi: 10.1158/1078-0432.CCR-22-0164. Clin Cancer Res. 2022. PMID: 35583610 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters